Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Thymoma × Carboplatin × Clear all

Phase

Status

Sponsor Class

OTHER 2 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Small Cell Lung Carcinoma 2 Pathologic Complete Response 2 Fallopian Tube Neoplasms 2 Adenocarcinoma of Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Non-squamous Cell Non-Small Cell Lung Cancer 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 HER2 Positive Breast Cancer 1 Endometrial Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 1 olaparib 1 lenvatinib 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05832827 2023-10-23

Artemis

National Cancer Center, Japan

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡